Application form: tablets, capsules
Indication group: otorhinolaryngologicals
Active substance: Benzoxonii chloridum 1 mg, Lidocaini hydrochloridum monohydricum 1 mg
minimum amount for dispatch: Orofar contains a substance effective against infection and a substance which causes desensitisation (anaesthetic). It is used for the treatment of inflammations of the oral cavity and the pharynx. Orofar is available in form of lozenges, spray and solution for rinsing or gargling.
Manufacturer: Novartis s.r.o., Prague, Czech Republic, www.novartis.com